Analysis of immunoglobulin glycosylation by LC‐ESI‐MS of glycopeptides and oligosaccharides

Two LC‐ESI‐MS methods for the analysis of antibody glycosylation are presented. In the first approach, tryptic glycopeptides are separated by RP chromatography and analyzed by ESI‐MS. This “glycopeptide strategy” allows a protein‐ and subclass‐specific quantitation of both neutral and sialylated glycan structures. Additional information about under‐ or deglycosylation and the protein backbone, e.g., termini, can be extracted from the same data. In the second LC‐ESI‐MS method, released oligosaccharides are separated on porous graphitic carbon (PGC). A complete structural assignment of neutral and sialylated oligosaccharides occurring on antibodies is thereby achieved in one chromatographic run. The two methods were applied to polyclonal human IgG, to commercial mAb expressed in CHO cells (Rituximab, Xolair, and Herceptin), in SP2/0 (Erbitux and Remicade) or NS0 cells (Zenapax) and the anti‐HIV antibody 4E10 produced either in CHO cells or in a human cell line. Both methods require comparably little sample preparation and can be applied to SDS‐PAGE bands. They both outperform non‐MS methods in terms of reliability of peak assignment and MALDI‐MS of underivatized glycans with regard to the recording of sialylated structures. Regarding fast and yet detailed structural assignment, LC‐MS on graphitic carbon supersedes all other current methods.

[1]  M. Van Montagu,et al.  Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds , 2007, Proceedings of the National Academy of Sciences.

[2]  David Passmore,et al.  Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor , 2006, Nature Biotechnology.

[3]  R. Jefferis,et al.  Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. , 1987, Biochemistry.

[4]  Alain Van Dorsselaer,et al.  Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  T. Raju,et al.  Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. , 2000, Glycobiology.

[6]  R. Huber,et al.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. , 2003, Journal of molecular biology.

[7]  André M Deelder,et al.  Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum , 2007, Proteomics.

[8]  N. Takahashi,et al.  Three-dimensional mapping of N-linked oligosaccharides using anion-exchange, hydrophobic and hydrophilic interaction modes of high-performance liquid chromatography. , 1996, Journal of chromatography. A.

[9]  S. Nishimura,et al.  Simple separation of isomeric sialylated N-glycopeptides by a zwitterionic type of hydrophilic interaction chromatography. , 2006, Journal of separation science.

[10]  R. Parekh,et al.  Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. , 1995, Analytical biochemistry.

[11]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[12]  A. Jones,et al.  Analysis of acidic oligosaccharides and glycopeptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 1996, Analytical chemistry.

[13]  R. Kunert,et al.  Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. , 2007, Plant biotechnology journal.

[14]  N. Packer,et al.  A general approach to desalting oligosaccharides released from glycoproteins , 1998, Glycoconjugate Journal.

[15]  Youwei Jiang,et al.  Optimization of humanized IgGs in glycoengineered Pichia pastoris , 2006, Nature Biotechnology.

[16]  Simon J North,et al.  Mass spectrometric analysis of N- and O-glycosylation of tissues and cells. , 2006, Current opinion in structural biology.

[17]  Lihua Huang,et al.  Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. , 2006, Analytical biochemistry.

[18]  R. Dwek,et al.  Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. , 2006, Arthritis and rheumatism.

[19]  G. Nicolaes,et al.  Biochemical, molecular characterization, and glycoproteomic analyses of α1‐proteinase inhibitor products used for replacement therapy * , 2006, Transfusion.

[20]  M. Butler,et al.  Comparisons of the Glycosylation of a Monoclonal Antibody Produced under Nominally Identical Cell Culture Conditions in Two Different Bioreactors , 2000, Biotechnology progress.

[21]  H. Yagi,et al.  Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. , 2006, Biochimica et biophysica acta.

[22]  L. Taylor,et al.  Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. , 1997, Analytical biochemistry.

[23]  Xiang Zhang,et al.  Data pre-processing in liquid chromatography-mass spectrometry-based proteomics , 2005, Bioinform..

[24]  Hildegard Geyer,et al.  Strategies for analysis of glycoprotein glycosylation. , 2006, Biochimica et biophysica acta.

[25]  H. Spiegelberg,et al.  The carbohydrate contents of fragments and polypeptide chains of human gamma-G-myeloma proteins of different heavy-chain subclasses. , 1968, Biochemistry.

[26]  F. Altmann,et al.  Enzymatic Properties and Subcellular Localization of Arabidopsis β-N-Acetylhexosaminidases1[W][OA] , 2007, Plant Physiology.

[27]  M. Tajiri,et al.  Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. , 2004, Analytical chemistry.

[28]  G. Rouwendal,et al.  Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. , 2007, Glycobiology.

[29]  R. Jefferis,et al.  A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. , 1990, The Biochemical journal.

[30]  D. Chargelegue,et al.  Antibody processing and engineering in plants, and new strategies for vaccine production. , 2005, Vaccine.

[31]  Michael Butler,et al.  A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. , 2002, Analytical biochemistry.

[32]  R. Dwek,et al.  A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. , 1996, Analytical biochemistry.

[33]  Yelena Lyubarskaya,et al.  A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodies. , 2006, Carbohydrate research.

[34]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[35]  C. Stemmer,et al.  In vivo glyco‐engineered antibody with improved lytic potential produced by an innovative non‐mammalian expression system , 2007, Biotechnology journal.

[36]  Naoyuki Taniguchi,et al.  Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. , 2007, Glycobiology.

[37]  P. Umaña,et al.  The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. , 2006, The Journal of biological chemistry.

[38]  Y. Mechref,et al.  Miniaturized separation techniques in glycomic investigations. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[39]  Uwe Kärst,et al.  Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. , 2003, Biotechnology and bioengineering.

[40]  J. Stadlmann,et al.  Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. , 2007, Analytical chemistry.

[41]  F. Altmann,et al.  Comprehensive glyco‐proteomic analysis of human α1‐antitrypsin and its charge isoforms , 2006, Proteomics.

[42]  Friedrich Altmann,et al.  The Drosophila fused lobes Gene Encodes an N-Acetylglucosaminidase Involved in N-Glycan Processing* , 2006, Journal of Biological Chemistry.

[43]  André M Deelder,et al.  Glycoproteomics based on tandem mass spectrometry of glycopeptides. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[44]  R. Dwek,et al.  Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. , 1997, Analytical biochemistry.

[45]  Akira Okazaki,et al.  Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. , 2007, Glycobiology.

[46]  R. Fischer,et al.  Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. , 2008, Plant biotechnology journal.

[47]  I. Shimada,et al.  Complete and rapid peptide and glycopeptide mapping of mouse monoclonal antibody by LC/MS/MS using ion trap mass spectrometry. , 1998, Analytical chemistry.

[48]  S. Nishimura,et al.  Structural analysis of an N-glycan with "beta1-4 bisecting branch" from human serum IgG by negative-ion MSn spectral matching and exoglycosidase digestion. , 2005, Analytical chemistry.

[49]  N. Avdalović,et al.  Analysis of carbohydrates on IgG preparations. , 1994, Journal of pharmaceutical sciences.

[50]  Li Yang,et al.  Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. , 2007, Analytical biochemistry.

[51]  S. Iida,et al.  Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies , 2006, Expert opinion on biological therapy.